The division debarred J. Solano HVAC LLC and its owner from bidding on federally funded construction projects for a period of ...

The B-cell depleting therapy is indicated for adults with generalized myasthenia gravis and anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibodies.

The FDA has approved Uplizna for generalized myasthenia gravis in adults who are anti-AChR and anti-MuSK antibody positive.

Archer Aviation is an early pioneer of the electric vertical takeoff and landing aircraft market. Management expects the ...

Detailed price information for Archer Aviation Inc (ACHR-N) from The Globe and Mail including charting and trades.

Archer is stacking global catalysts fast, from Tokyo to Los Angeles to Saudi Arabia, and a new powertrain revenue stream ...

Archer Aviation (NYSE:ACHR) presents an intriguing conundrum for investors, offering both enormous promise but also plenty of ...

One of the most effective ways to attract new talent is by establishing clear, accessible pathways into the trades. That’s ...

Archer Aviation Inc. (NYSE:ACHR) is one of the Best Aerospace Stocks to Buy According to Analysts. On December 9, Archer ...

Amgen receives US FDA approval for Uplizna to treat Adults with generalized myasthenia gravis: Thousand Oaks, California Saturday, December 13, 2025, 11:00 Hrs [IST] Amgen announc ...

In recent years, five other drugs have been approved to treat gMG, including three complement inhibitors -- eculizumab (Soliris), ravulizumab (Ultomiris), and zilucoplan (Zilbrysq) – and two neonatal ...

The Muscular Dystrophy Association (MDA) recognizes the U.S. Food and Drug Administration (FDA) approval of Amgen’s UPLIZNA ® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis ...